Morvus Technology Overview
- Year Founded
-
2004
- Status
-
Private
- Employees
-
5
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$2.28M
- Investors
-
3
Morvus Technology General Information
Description
Developer of novel drugs and diagnostics designed for the oncology sector. The company specializes in drug discovery and creates therapeutic drugs and diagnostics for lung cancer, tumors, and other oncological diseases.
Contact Information
Website
www.morvus.comCorporate Office
- Llanvetherine Court
- Llanvetherine
- Abergavenny NP7 8NL
- Wales, United Kingdom
Corporate Office
- Llanvetherine Court
- Llanvetherine
- Abergavenny NP7 8NL
- Wales, United Kingdom
Morvus Technology Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
5. Later Stage VC | 04-Nov-2019 | $2.28M | Completed | Generating Revenue | ||
4. Later Stage VC | 31-Mar-2017 | Completed | Generating Revenue | |||
3. Grant | 12-Jul-2010 | Completed | Clinical Trials - Phase 1 | |||
2. Early Stage VC (Series A) | 04-Dec-2009 | $3.57M | $3.57M | Completed | Startup | |
1. University Spin-Out | 01-Jan-2004 | Completed | Startup |
Morvus Technology Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Ordinary | ||||||||
Ordinary | ||||||||
Ordinary | 88,386,427 | $0.001272 | $0.14 | $0.14 | 1x | $0.14 | 34.18% |
Morvus Technology Patents
Morvus Technology Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20100137140-A1 | Method and substance for promoting plant growth | Inactive | 02-Apr-2007 | ||
GB-0619326-D0 | Vermin poison | Inactive | 30-Sep-2006 | ||
GB-2442202-A | Vermin poison | Inactive | 30-Sep-2006 | ||
ES-2553881-T3 | Pest poison | Active | 30-Sep-2006 | ||
CA-2694341-C | Vermin poison | Inactive | 30-Sep-2006 | A01N25/004 |
Morvus Technology Board Members (4)
Name | Representing | Role | Since |
---|---|---|---|
David Baynes | FusionIP | Board Member | |
Jonathan Beatson-Hird | Cardiff Protides | Board Member | |
Michael Wyllie Ph.D | Self | Chairman |
Morvus Technology Signals
Morvus Technology Investors (3)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
National Institute for Health Research | Government | |||
FusionIP | Venture Capital | Minority | ||
IP Group | Venture Capital | Minority |
Morvus Technology Acquisitions (1)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Cardiff Protides | 10-Oct-2007 | Drug Discovery |
Morvus Technology Subsidiaries (2)
Company Name | Industry | Location | Founded |
---|---|---|---|
Gordian Pharma | Biotechnology | Brecon, United Kingdom | 2020 |
Cardiff Protides | Drug Discovery | Brecon, United Kingdom |
Morvus Technology FAQs
-
When was Morvus Technology founded?
Morvus Technology was founded in 2004.
-
Who is the founder of Morvus Technology?
Philip Burke is the founder of Morvus Technology.
-
Where is Morvus Technology headquartered?
Morvus Technology is headquartered in Abergavenny, United Kingdom.
-
What is the size of Morvus Technology?
Morvus Technology has 5 total employees.
-
What industry is Morvus Technology in?
Morvus Technology’s primary industry is Drug Discovery.
-
Is Morvus Technology a private or public company?
Morvus Technology is a Private company.
-
What is the current valuation of Morvus Technology?
The current valuation of Morvus Technology is
. -
What is Morvus Technology’s current revenue?
The current revenue for Morvus Technology is
. -
How much funding has Morvus Technology raised over time?
Morvus Technology has raised $17.5M.
-
Who are Morvus Technology’s investors?
National Institute for Health Research, FusionIP, and IP Group have invested in Morvus Technology.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »